Research outputs
2025
The biological consequences and clinical implications of extracellular histone binding to coagulation Factors I and II
Yong, J. X. (2025, July 9). The biological consequences and clinical implications of extracellular histone binding to coagulation Factors I and II. (University of Liverpool).
2024
Revisiting the full blood count: Circulating blood cells and their role in coagulation.
Schofield, J., Yong, J., & Toh, C. -H. (2024). Revisiting the full blood count: Circulating blood cells and their role in coagulation.. British journal of haematology. doi:10.1111/bjh.19690
Fibrinogen binding to histones in circulation protects against adverse cellular and clinical outcomes.
Toh, J. M., Yong, J., Abrams, S. T., Wang, L., Schofield, J., Lane, S., . . . Toh, C. -H. (2024). Fibrinogen binding to histones in circulation protects against adverse cellular and clinical outcomes.. Journal of thrombosis and haemostasis : JTH, 22(8), 2247-2260. doi:10.1016/j.jtha.2024.05.009
The convergent model of coagulation.
Yong, J., & Toh, C. -H. (2024). The convergent model of coagulation.. Journal of thrombosis and haemostasis : JTH, 22(8), 2140-2146. doi:10.1016/j.jtha.2024.05.014
2023
Rethinking coagulation: from enzymatic cascade and cell-based reactions to a convergent model involving innate immune activation.
Yong, J., & Toh, C. -H. (2023). Rethinking coagulation: from enzymatic cascade and cell-based reactions to a convergent model involving innate immune activation.. Blood, 142(25), 2133-2145. doi:10.1182/blood.2023021166
Cell-free histones and the cell-based model of coagulation.
Yong, J., Abrams, S. T., Wang, G., & Toh, C. -H. (2023). Cell-free histones and the cell-based model of coagulation.. Journal of thrombosis and haemostasis : JTH, S1538-7836(23)00340-9. doi:10.1016/j.jtha.2023.04.018
2022
The Importance of Pore-Forming Toxins in Multiple Organ Injury and Dysfunction
Abrams, S. T. T., Wang, L., Yong, J., Yu, Q., Du, M., Alhamdi, Y., . . . Wang, G. (2022). The Importance of Pore-Forming Toxins in Multiple Organ Injury and Dysfunction. BIOMEDICINES, 10(12). doi:10.3390/biomedicines10123256
Anti-AnWj antibody induced haemolytic transfusion reaction in a patient with primary acquired pure red cell aplasia
Yong, J., Johnstone, M., Callaghan, T., Chandrasekar, A., & Pervaiz, M. S. (2022). Anti-AnWj antibody induced haemolytic transfusion reaction in a patient with primary acquired pure red cell aplasia. TRANSFUSION MEDICINE, 32(4), 346-348. doi:10.1111/tme.12884
2021
CD56 positive central nervous system plasmacytosis in a patient with refractory CD56 negative primary plasma cell leukaemia.
Yong, J., Schofield, J., Lawton, D., & Brearton, G. (2021). CD56 positive central nervous system plasmacytosis in a patient with refractory CD56 negative primary plasma cell leukaemia.. EJHaem, 2(4), 871-872. doi:10.1002/jha2.271
Real-world experience with caplacizumab in the management of acute TTP
Dutt, T., Shaw, R. J., Stubbs, M., Yong, J., Bailiff, B., Cranfield, T., . . . Scully, M. (2021). Real-world experience with caplacizumab in the management of acute TTP. BLOOD, 137(13), 1731-1740. doi:10.1182/blood.2020007599
Answer to March 2021 Photo Quiz.
Adler, H., Cruise, J., Yong, J., Patel, A., Mikhail, M., Beadsworth, M. B. J., & Beeching, N. J. (2021). Answer to March 2021 Photo Quiz.. Journal of clinical microbiology, 59(3), e00119-e00120. doi:10.1128/jcm.00119-20
Photo Quiz: Disseminated Violaceous Skin Lesions following Allogeneic Stem Cell Transplant
Adler, H., Cruise, J., Yong, J., Patel, A., Mikhail, M., Beadsworth, M. B. J., & Beeching, N. J. (2021). Photo Quiz: Disseminated Violaceous Skin Lesions following Allogeneic Stem Cell Transplant. JOURNAL OF CLINICAL MICROBIOLOGY, 59(3). doi:10.1128/JCM.00118-20
2020
Rapid cognitive decline in a patient with chronic lymphocytic leukaemia: a case report
Forryan, J., & Yong, J. (2020). Rapid cognitive decline in a patient with chronic lymphocytic leukaemia: a case report. JOURNAL OF MEDICAL CASE REPORTS, 14(1). doi:10.1186/s13256-020-2360-9
2019
Elimination of Acute GvHD with Three Doses of Abatacept Prophylaxis Combined with Post-Transplant Cyclophosphamide after Myeloablative Treosulfan-Based Conditioning in the HLA Identical Sibling and Unrelated (10-12/12) Peripheral Blood Stem Cell Donor Setting: Improved Safety and Efficacy Compared to Alemtuzumab Prophylaxis
Patel, A., & Yong, J. (2019). Elimination of Acute GvHD with Three Doses of Abatacept Prophylaxis Combined with Post-Transplant Cyclophosphamide after Myeloablative Treosulfan-Based Conditioning in the HLA Identical Sibling and Unrelated (10-12/12) Peripheral Blood Stem Cell Donor Setting: Improved Safety and Efficacy Compared to Alemtuzumab Prophylaxis. In BLOOD Vol. 134. doi:10.1182/blood-2019-130184
2018
Case Report: Haemolytic anaemia with ceftazidime use in a patient with cystic fibrosis.
Yong, J., Frost, F., Nazareth, D., & Walshaw, M. (2018). Case Report: Haemolytic anaemia with ceftazidime use in a patient with cystic fibrosis.. F1000Research, 7, 475. doi:10.12688/f1000research.14505.1